(Date:11/30/2009)...TTLE, Nov. 30 Cell Thera...ed today that its new class of platinum-based anti...ted a stronger anti-tumor potency and activity com...nds as well as the ability to overcome cisplatin-r...presented in a paper titled "Novel Bis-platinum Co...
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNews...ublisher of scientific, medical and technical prod...ch of Embase, its comprehensive biomedical,databas... more than 7,000,active, peer reviewed journals. ,... advancement of new biomedical,and pharmaceutical ...
(Date:11/27/2009)..., November 27 Stallergen...alair(R) in both adults and children,through a Mut...try where,Oralair(R) has been marketed, was the re... registered in Austria, Belgium, Bulgaria, Cyprus,...ece, Hungary, Ireland, Italy,Latvia, Lithuania, L...
(Date:11/25/2009)...TON, Nov. 25 Biotech firm Replikin... data from the 1918 pandemic through the predictio...emic, today issued its latest biochemical analysis...ty of the H1N1 ("Swine Flu") virus has dropped fro...rrent outbreak in the spring of 2009 to resting no...
Breaking Biology Technology:New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5... Accumetrics, Inc. has appointed,Timothy I. Still ...cer. Mr.,Still has been serving in the capacity of...pany since earlier this year., "Tim has the right...experience for our Board," says Tony Arnerich, Gen...hairman of the Board at Accumetrics. "His,commerci...
...ct. 30 Idenix,Pharmaceuticals, Inc. (Nasdaq: IDI...scovery and development of drugs for the treatment...ay reported unaudited financial results,for the th...08. At,September 30, 2008, Idenix,s cash, cash equ...mately $60.1 million., 2008 Year-to-Date Business...
...ers Aid in the Diagnosis of Infectious and Inflamm...n Deficiency, MUNDELEIN, Ill., Oct. 30 Sysmex Am... Food and Drug Administration (FDA) has,cleared Sy...iculocyte,Hemoglobin Equivalent (RET-He) parameter...Hematology Analyzers for low to mid-volume,laborat...
Other Biology Technology:Timothy I. Still Appointed CEO at Accumetrics 2Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 2Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 3Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 4Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 5Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 6Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 7Sysmex America Set to Launch New XT-Series(TM) Parameters 2Rabbit Anti-MPV17 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Custom siRNA, standard purity, annealed from Ambion
... custom siRNA service provides the premium quality... Custom siRNAs can be readily ordered online by pr...by providing the sense and antisense siRNA sequenc...d Silencer Pre-designed siRNAs, which are already ...
...39;s custom siRNA service provides the premium qua...rch. Custom siRNAs can be readily ordered online b... or by providing the sense and antisense siRNA seq...lidated and Silencer Pre-designed siRNAs, which ...
Biology Products: